The expression of ST14 mRNA was significantly increased in bladder cancer, breast cancer, lung cancer, ovarian cancer, prostate cancer, and other cancer, and the expression was decreased in kidney cancer, melanoma, and sarcoma (Fig. 1A). Here, ST14 is linked to nephrotic syndrome.